A new generation of preclinical assays – the 3D CoSeedis™ in chip principle
The 3D CoSeedis™ in chip assays are at the core of all our service packages and are essential to their outstanding performance. The underlying proprietary technology allows us to address organoid systems consisting of various cell types that up till now eluded closer examination in a 3D context.
Furthermore, it generates the environment that enables the analysis of large quantities of uniformly formed and homogenously grown 3D structures. It is the particular and unique in chip technology that boost statistical relevance of our results into new spheres and therefore defines a new generation of preclinical assay.
We understand that every research project is unique. That is why our assay services show the highest possible level of flexibility and can be tailored and adapted to your specific needs. During a project, our team collaborates closely with you, customizes the assays where required and optimizes protocols for optimal outcomes. Contact us and implement our unmatched accuracy and reliability in your research.
Selection of most prominent 3D CoSeedis™ in chip assays:
- 3D CoSeedis™ Apoptosis in chip Assay
- 3D CoSeedis™ Co-Culture Assay
- 3D CoSeedis™ Cytotoxicity in chip Assay
- 3D CoSeedis™ Dose Response Assay
- 3D CoSeedis™ Drug Efficacy Assay
- 3D CoSeedis™ Tumor Relapse Assay
- 3D CoSeedis™ Histology Assay
- 3D CoSeedis™ Standard Assay
- 3D CoSeedis™ Live Cell Detection in chip Assay
- 3D CoSeedis™ Antibody Penetration Assay
- 3D CoSeedis™ Late Stage Cancer Relapse Assay
- 3D CoSeedis™ Colony Forming in chip Assay
- 3D CoSeedis™ Off-Target Cytotoxicity in chip Assay